ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,601 | 80.33398 | 0 | male | 0 | 9 | 2,027 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 15,306 | 9,417.1719 | null | 16 | white | 17.097656 | 27 | 0.8479 | 0.750977 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 9 | 56 | 14.199219 | 75 | 20 | 37 | 337 | 3.599609 | null | 1.199951 | 142 | 7.399414 | null | null | null | null | null | null | 2.839356 |
1,602 | 62.84497 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 79,451 | 59,804.6562 | null | 51 | white | 42.09375 | 59 | 0.284973 | 0.175995 | 20 | 0 | 0 | no | null | null | dnr after sadm | 5 | 40 | 18.097656 | 158 | 28 | 37.59375 | 240 | null | null | 4.5 | 135 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.370606 |
1,603 | 56.91199 | 1 | male | 0 | 14 | 40 | Lung Cancer | Cancer | 1 | 15 | $25-$50k | 9 | 13,620 | 12,023.5703 | null | 9.333328 | white | 23.898438 | 41 | 0.529907 | 0.20697 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr before sadm | -1 | 60 | 7.099609 | 140 | 40 | 38.29688 | 304.75 | 3 | 0.599976 | 0.799927 | 136 | 7.439453 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
1,604 | 44.47897 | 1 | female | 0 | 22 | 111 | Lung Cancer | Cancer | 1 | 13 | $25-$50k | 100 | 25,121 | 20,401.625 | null | 13 | white | 32.898438 | 28 | 0.012999 | 0 | 1 | 0 | 0 | metastatic | 0.5 | 0.4 | dnr after sadm | 1 | 67 | 8.099609 | 107 | 8 | 36.29688 | 381.625 | 2.399902 | 0.399963 | 1.399902 | 136 | 7.339844 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.907715 |
1,605 | 29.13599 | 1 | male | 0 | 15 | 59 | MOSF w/Malig | ARF/MOSF | 1 | 18 | null | 0 | 20,860 | 16,367.9531 | null | 9.666664 | white | 31.199219 | 42 | 0.588989 | 0.480957 | 1 | 0 | 0 | yes | 0.2 | 0.05 | dnr after sadm | 1 | 67 | 27.898438 | 112 | 24 | 38.29688 | null | 1.899902 | 3.699707 | 1.099854 | 118 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,606 | 82.06396 | 0 | male | 0 | 4 | 2,024 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 3,265 | 2,432.3867 | null | 14 | white | 18.796875 | 37 | 0.821899 | 0.709961 | 1 | 1 | 0 | no | 0.6 | 0.5 | no dnr | 4 | 70 | 16.898438 | 80 | 20 | 36.09375 | 290.4375 | null | null | 1.5 | 135 | 7.489258 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,607 | 54.63699 | 0 | male | 0 | 12 | 2,024 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 10,749 | 8,246.9922 | null | 12 | white | 21.5 | 40 | 0.875 | 0.791992 | 1 | 0 | 0 | no | 0.5 | 0.2 | no dnr | 12 | 79 | 10.099609 | 124 | 42 | 40.09375 | 227.5 | 4.099609 | 1 | 1.199951 | 132 | 7.489258 | null | null | null | null | null | null | 2.42627 |
1,608 | 90.89099 | 1 | female | 0 | 16 | 64 | Colon Cancer | Cancer | 2 | 11 | null | 0 | 13,201 | 10,254.375 | null | 6 | other | 15.199219 | 27 | 0.791992 | 0.56189 | 1 | 1 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 1 | 81 | 7 | 80 | 20 | 36.5 | 323.75 | 3.599609 | 0.899902 | 1.599854 | 135 | 7.30957 | null | null | null | 2 | 2 | null | 2 |
1,609 | 70.80396 | 1 | female | 0 | 12 | 18 | Lung Cancer | Cancer | 4 | 12 | null | 0 | 13,253 | 10,580.3281 | null | 7.5 | white | 24.097656 | 33 | 0.521973 | 0.199982 | 1 | 0 | 0 | metastatic | 0.7 | 0.1 | dnr after sadm | 1 | 73 | 11.798828 | 120 | 28 | 36.09375 | 395.1875 | 3.399902 | 0.5 | 1.199951 | 135 | 7.449219 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
1,610 | 82.11896 | 0 | female | 0 | 3 | 2,022 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | null | 0 | 3,189 | 2,218.0117 | null | 12 | white | 18.296875 | 23 | 0.827881 | 0.718994 | 1 | 1 | 1 | no | 1 | 0.75 | no dnr | 3 | 92 | 6.299805 | 60 | 24 | 36.29688 | null | null | null | 1.599854 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.983887 |
1,611 | 30.03999 | 0 | male | 0 | 12 | 2,022 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 0 | 17,692 | 9,315.7969 | null | 16.5 | black | 18.398438 | 12 | 0.932983 | 0.907959 | 1 | 0 | 0 | no | 0.85 | 0.85 | no dnr | 12 | 89 | 9.699219 | 102 | 24 | 38.69531 | null | 2.299805 | 0.399963 | 0.5 | 146 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.202637 |
1,612 | 83.65796 | 1 | female | 0 | 9 | 744 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 6,931 | 5,280.9766 | null | 5.5 | white | 20.296875 | 25 | 0.793945 | 0.667969 | 1 | 0 | 0 | no | 0.5 | 0.125 | dnr after sadm | 1 | 95 | 18.699219 | 104 | 25 | 37.29688 | 504.0625 | null | null | 1.199951 | 146 | 7.5 | null | null | null | 1 | 3 | no(M2 and SIP pres) | 3 |
1,613 | 77.66699 | 1 | male | 1 | 20 | 20 | CHF | COPD/CHF/Cirrhosis | 3 | 15 | null | 0 | 16,398 | 13,352.3125 | null | 5.333332 | white | 16 | 42 | 0.86792 | 0.780884 | 1 | 1 | 0 | no | 0.8 | 0.512 | no dnr | 20 | 69 | 9.898438 | 74 | 16 | 36.79688 | 204 | 4.199219 | null | 2.299805 | 137 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.988281 |
1,614 | 93.75494 | 1 | female | 0 | 13 | 102 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 10,622 | 8,300.2734 | null | 14.5 | white | 21.699219 | 53 | 0.723999 | 0.56897 | 1 | 0 | 0 | no | 0.95 | 0.9 | dnr after sadm | 1 | 66 | 5.099609 | 140 | 36 | 38.69531 | null | 3.799805 | null | 1.799805 | 136 | null | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
1,615 | 63.48499 | 1 | female | 0 | 23 | 52 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 22,166 | 18,582.3438 | null | 13.333328 | black | 34.296875 | 28 | 0.25 | 0.031998 | 1 | 0 | 0 | metastatic | 0.65 | 0.35 | dnr after sadm | 1 | 53 | 20.296875 | 112 | 20 | 37.29688 | null | 2.699707 | 0.5 | 0.799927 | 133 | null | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
1,616 | 58.63898 | 0 | male | 0 | 15 | 2,019 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 17,714 | 11,645.3594 | null | 20.333328 | white | 38.195313 | 42 | 0.485962 | 0.283997 | 1 | 0 | 0 | yes | 0.5 | 0.02 | no dnr | 15 | 49 | 14.5 | 118 | 32 | 36.19531 | 243.3125 | 3.299805 | 1.299805 | 1.099854 | 124 | 7.459961 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,617 | 84.10095 | 1 | female | 0 | 42 | 1,115 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 9 | 42,058 | 28,787.5156 | null | 14.5 | white | 22.5 | 39 | 0.731934 | 0.647949 | 1 | 1 | 0 | no | null | null | no dnr | 42 | 65 | 18.398438 | 44 | 24 | 37.29688 | 388 | 2.199707 | 1.099854 | 1.899902 | 142 | 7.329102 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
1,618 | 51.52399 | 0 | female | 0 | 10 | 2,017 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 9,931 | 5,960.7148 | null | 18.5 | white | 24.097656 | 21 | 0.753906 | 0.67688 | 1 | 0 | 0 | no | 0.99 | 0.98 | no dnr | 10 | 63 | 3.599609 | 98 | 40 | 39.09375 | 302.5 | 3 | 0.399963 | 0.599976 | 136 | 7.439453 | null | null | null | null | null | null | 2.415039 |
1,619 | 95.56494 | 1 | female | 0 | 5 | 1,668 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 4,417 | 3,155.0312 | null | 10 | white | 22.199219 | 56 | 0.705933 | 0.543945 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 5 | 77 | 12.699219 | 160 | 28 | 36.69531 | 460 | 4 | 1.199951 | 1.699951 | 144 | 7.459961 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
1,620 | 55.42499 | 1 | female | 0 | 11 | 93 | Lung Cancer | Cancer | 1 | 13 | null | 0 | 10,085 | 7,489.4961 | null | 12.5 | white | 32.296875 | 14 | 0.335999 | 0.066986 | 1 | 0 | 0 | metastatic | 0.2 | 0 | dnr after sadm | 2 | 73 | 8 | 104 | 24 | 37 | null | 2.599609 | 0.899902 | 0.799927 | 128 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.220703 |
1,621 | 53.42099 | 0 | male | 0 | 9 | 2,016 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 14,593 | 8,761.5156 | null | 14 | white | 15.199219 | 13 | 0.919922 | 0.890991 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 9 | 83 | 13.599609 | 78 | 32 | 38.29688 | null | 2.799805 | null | 1 | 138 | null | null | null | null | 0 | null | null | 0.4948 |
1,622 | 84.33099 | 0 | male | 0 | 12 | 2,016 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 17,909 | 13,563.3047 | null | 22 | white | 21.898438 | 34 | 0.768921 | 0.694946 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 12 | 75 | 10.398438 | 68 | 16 | 38.5 | 108 | 3.799805 | 0.299988 | 1.399902 | 142 | 7.40918 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,623 | 57.23199 | 1 | female | 0 | 5 | 236 | Lung Cancer | Cancer | 1 | 9 | $11-$25k | 0 | 4,652 | 3,553.2793 | null | 16 | asian | 8.298828 | 10 | 0.853882 | 0.67688 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 5 | 107 | 7.5 | 100 | 18 | 36.89844 | null | 4.199219 | null | 0.899902 | 142 | null | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
1,624 | 46.74597 | 0 | female | 0 | 45 | 2,015 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | null | 0 | 94,302 | 24,157.2031 | null | 34 | white | 32 | 44 | 0.75 | 0.670898 | 1 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 45 | 103 | 3.099609 | 158 | 10 | 39.59375 | 200 | 2.199707 | 3.599609 | 0.699951 | 132 | 7.279297 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,625 | 87.20099 | 1 | female | 0 | 23 | 217 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 21,775 | 14,229.2656 | null | 10 | white | 14.798828 | 31 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 23 | 67 | 8.199219 | 88 | 24 | 38 | 453 | null | null | 1.599854 | 139 | 7.459961 | null | null | null | null | 0 | null | 0 |
1,626 | 80.29596 | 1 | female | 1 | 7 | 7 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 11,442 | 3,974.5703 | null | 26 | white | 20 | 20 | 0.780884 | 0.649902 | 1 | 0 | 0 | no | 0.3 | 0.1 | no dnr | 7 | 98 | 5 | 40 | 24 | 38 | 200 | null | 0.5 | 0.599976 | 141 | 7.359375 | null | null | null | 5 | 2 | <2 mo. follow-up | 2 |
1,627 | 78.26099 | 1 | male | 0 | 9 | 176 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 13,574 | 10,652.4219 | null | 18.5 | null | 25.296875 | 31 | 0.700928 | 0.53894 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr before sadm | -1 | 75 | 7 | 103 | 20 | 38 | 127.5 | null | null | 1.099854 | 128 | 7.509766 | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
1,628 | 75.99695 | 1 | male | 0 | 39 | 1,423 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 81,626 | 562.814 | null | 29.25 | white | 20.898438 | 37 | 0.782959 | 0.711914 | 4 | 0 | 0 | no | null | null | no dnr | 39 | 112 | 9.298828 | 83 | 18 | 38.39844 | 196 | 3 | null | 3.799805 | 139 | 7.399414 | null | null | null | 1 | null | adl>=4 (>=5 if sur) | 1.1669 |
1,629 | 60.86798 | 1 | male | 0 | 128 | 476 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 4 | null | 9 | 259,334 | 74,035.125 | null | 25.25 | white | 24.296875 | 48 | 0.73291 | 0.649902 | 12 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 128 | 129 | 10.298828 | 114 | 28 | 37.19531 | 376.625 | null | null | 10.898438 | 134 | 7.339844 | null | null | null | null | 2 | null | 2 |
1,630 | 57.11697 | 1 | male | 0 | 5 | 375 | Lung Cancer | Cancer | 1 | 12 | >$50k | 0 | 8,150 | 5,800.4766 | null | 15 | white | 11.898438 | 9 | 0.809937 | 0.593994 | 1 | 0 | 0 | metastatic | 0.8 | 0.4 | no dnr | 5 | 93 | 6.699219 | 84 | 20 | 38 | null | null | 0.399963 | 1 | 142 | null | null | null | null | null | 2 | null | 2 |
1,631 | 67.38898 | 1 | male | 0 | 5 | 38 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 6,146 | 3,244.582 | null | 6 | white | 14.398438 | 13 | 0.896973 | 0.826904 | 2 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 5 | 80 | null | 80 | 24 | 36.69531 | null | null | null | 1.299805 | 144 | null | null | null | null | 6 | null | <2 mo. follow-up | 4.527397 |
1,632 | 71.90094 | 0 | male | 0 | 9 | 2,010 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 15 | null | 26 | 27,244 | 20,179.2031 | null | 21 | white | 22.796875 | 31 | 0.598999 | 0.490967 | 6 | 0 | 0 | yes | null | null | no dnr | 9 | 75 | 6.699219 | 58 | 12 | 36 | 214.28125 | null | 0.399963 | 1.899902 | 137 | 7.399414 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,633 | 21.20999 | 0 | male | 0 | 5 | 2,009 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 6,719 | 3,303.125 | null | 7 | white | 19.5 | 45 | 0.937988 | 0.914917 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 129 | 8.298828 | 70 | 26 | 36.19531 | 306.625 | 3.099609 | 0.299988 | 12.398438 | 156 | 7.239258 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,634 | 53.67297 | 1 | male | 1 | 3 | 3 | Coma | Coma | 0 | 17 | $11-$25k | 100 | 6,521 | 2,071.1094 | null | 22 | black | 54.695313 | 81 | 0 | 0 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 33 | 5.099609 | 0 | 0 | 35.19531 | 211.65625 | 3.199707 | 0.5 | 2.399902 | 145 | 7.379883 | null | null | null | null | null | <2 mo. follow-up | 2.29834 |
1,635 | 71.45197 | 0 | female | 0 | 5 | 2,008 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 4,995 | 4,014.6133 | null | 7 | black | 18.097656 | 26 | 0.863892 | 0.773926 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 5 | 110 | 4.599609 | 66 | 20 | 36.79688 | 176.65625 | null | 0.299988 | 1.5 | 141 | 7.179688 | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
1,636 | 76.15094 | 1 | male | 1 | 26 | 26 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 16,484 | 13,867.6016 | null | 3.75 | white | 30.097656 | 18 | 0.326965 | 0.062988 | 1 | 0 | 0 | metastatic | 0.2 | 0.05 | dnr after sadm | 1 | 77 | 9.5 | 100 | 22 | 36.69531 | null | 2.699707 | 0.399963 | 0.699951 | 128 | null | null | null | null | 7 | 4 | <2 mo. follow-up | 4 |
1,637 | 64.99396 | 0 | male | 0 | 6 | 2,005 | CHF | COPD/CHF/Cirrhosis | 1 | 17 | $11-$25k | 0 | 7,826 | 3,351.7012 | null | 7 | white | 19.898438 | 24 | 0.862915 | 0.773926 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 6 | 73 | 4 | 114 | 20 | 36.19531 | null | null | null | 1.299805 | 137 | null | null | null | null | 0 | 0 | SIP>=30 | 0 |
1,638 | 37.81 | 0 | male | 0 | 17 | 2,005 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 57,170 | 420.3059 | null | 36 | white | 44.898438 | 81 | 0.420959 | 0.301941 | 6 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 17 | 47 | 17.898438 | 147 | 40 | 38.89844 | 80 | 2.299805 | null | 2.299805 | 138 | 7.369141 | null | null | null | null | 0 | null | 0 |
1,639 | 42.01498 | 0 | male | 0 | 8 | 2,004 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 17 | under $11k | 0 | 9,923 | 6,147.9219 | null | 13 | white | 19.296875 | 23 | 0.910889 | 0.878906 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 8 | 73 | 7.599609 | 50 | 16 | 36.79688 | 309.5 | 4.699219 | 1.299805 | 0.599976 | 135 | 7.449219 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,640 | 62.84698 | 1 | male | 1 | 29 | 29 | MOSF w/Malig | ARF/MOSF | 2 | 14 | under $11k | 0 | 46,029 | 28,832.4688 | null | 16 | white | 30.699219 | 49 | 0.36499 | 0.246979 | 8 | 1 | 0 | metastatic | 0.6 | 0.216 | dnr after sadm | 22 | 63 | 32.398438 | 66 | 28 | 36.79688 | 200 | 2.899902 | 1.099854 | 4.099609 | 128 | 7.399414 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
1,641 | 74.77899 | 1 | male | 0 | 7 | 1,769 | CHF | COPD/CHF/Cirrhosis | 1 | 9 | under $11k | 0 | 10,348 | 9,178.2422 | null | 8 | white | 19.5 | 27 | 0.815918 | 0.701904 | 3 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 7 | 65 | 11.199219 | 68 | 22 | 36 | null | null | null | 1.599854 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,642 | 79.67694 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 27,784 | 20,989 | null | 38 | white | 20.796875 | 34 | 0.751953 | 0.67395 | 8 | 1 | 0 | no | 0.4 | 0.2 | dnr after sadm | 1 | 73 | 12.298828 | 77 | 22 | 36.29688 | 296.625 | null | 0.299988 | 2.399902 | 137 | 7.449219 | null | null | null | 6 | 5 | <2 mo. follow-up | 5 |
1,643 | 24.78 | 0 | female | 0 | 13 | 1,999 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | under $11k | 0 | 20,322 | 12,712.5781 | null | 16 | black | 24.796875 | 23 | 0.876953 | 0.832886 | 6 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 13 | 60 | 13.199219 | 115 | 28 | 37 | 204.0625 | null | null | 0.599976 | 137 | 7.459961 | null | null | null | 0 | 4 | null | 4 |
1,644 | 72.95294 | 1 | male | 0 | 16 | 29 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 13,340 | 11,943.1562 | null | 7 | white | 16.296875 | 18 | 0.702881 | 0.416992 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 62 | 7.699219 | 62 | 16 | 36.5 | null | 3.599609 | 0.699951 | 0.799927 | 132 | null | null | null | null | null | 2 | <2 mo. follow-up | 2 |
1,645 | 31.56699 | 0 | male | 0 | 43 | 1,998 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 18 | null | 0 | 46,374 | 29,131.6406 | null | 13.25 | white | 30.097656 | 42 | 0.791992 | 0.723999 | 1 | 0 | 0 | yes | 1 | 0.99 | no dnr | 43 | 57 | 17.699219 | 130 | 34 | 39.59375 | 167.34375 | 2.699707 | 0.799927 | 1.5 | 138 | 7.379883 | null | null | null | 1 | 1 | null | 1 |
1,646 | 56.961 | 0 | male | 0 | 17 | 1,998 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 16 | $25-$50k | 0 | 19,128 | 13,759.375 | null | 13.666664 | white | 17.097656 | 26 | 0.844971 | 0.744995 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 17 | 71 | 6 | 77 | 32 | 37 | 306.625 | 2.5 | 2.5 | 0.799927 | 135 | 7.429688 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,647 | 85.31995 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 10,257 | 7,788.1328 | null | 35 | white | 23.097656 | 52 | 0.744995 | 0.665894 | 1 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 2 | 57 | 11.798828 | 155 | 8 | 38.69531 | 310 | 3.199707 | 0.399963 | 1.5 | 140 | 7.259766 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
1,648 | 65.70599 | 1 | female | 1 | 4 | 4 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 2,924 | 2,225.625 | null | 7 | white | 44.898438 | 79 | 0.139984 | 0.007999 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 53 | 0.299988 | 112 | 30 | 36.69531 | 661.625 | 1.699951 | 1.099854 | 1.399902 | 141 | 7.289062 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,649 | 87.19196 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 0 | 15,135 | 13,666.3828 | null | 31 | white | 48 | 68 | 0.071991 | 0.025997 | 3 | 1 | 0 | no | 0 | 0 | dnr after sadm | 1 | 30 | 23.699219 | 55 | 10 | 37.59375 | 197.5 | null | null | 2.5 | 130 | 7.289062 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
1,650 | 73.35199 | 0 | male | 0 | 12 | 1,994 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 16,690 | 13,542.2344 | null | 20.5 | white | 14.699219 | 26 | 0.795898 | 0.671997 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 73 | 8.298828 | 88 | 32 | 38.19531 | 350 | 2.699707 | null | 0.899902 | 146 | 7.439453 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
1,651 | 88.89795 | 1 | female | 0 | 14 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 15,777 | 8,660.6016 | null | 15 | white | 23 | 42 | 0.731934 | 0.647949 | 1 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 56 | 6.599609 | 51 | 12 | 37.59375 | 247.59375 | 2.5 | 0.299988 | 0.399963 | 140 | 7.429688 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
1,652 | 68.26294 | 1 | male | 0 | 7 | 20 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 5,599 | 4,413.5742 | null | 21 | white | 30 | 36 | 0.359985 | 0.078995 | 1 | 1 | 0 | metastatic | 0.5 | 0.1 | dnr before sadm | -1 | 77 | 13.199219 | 110 | 28 | 36 | null | 2.899902 | 0.599976 | 1 | 135 | null | null | null | null | 3 | null | <2 mo. follow-up | 2.511099 |
1,653 | 72.47595 | 0 | male | 0 | 38 | 1,993 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 55,572 | 46,378.6875 | null | 26.75 | white | 24 | 38 | 0.784912 | 0.654907 | 1 | 1 | 0 | no | 0.5 | 0.4 | dnr after sadm | 28 | 61 | 6.099609 | 97 | 9 | 38.39844 | 156 | null | null | 2.5 | 135 | 7.419922 | null | null | null | null | 0 | null | 0 |
1,654 | 64.54999 | 1 | female | 0 | 13 | 25 | Lung Cancer | Cancer | 1 | 15 | $11-$25k | 0 | 10,349 | 7,812.418 | null | 10 | white | 16.097656 | 11 | 0.725952 | 0.452942 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 3 | 83 | 8 | 90 | 20 | 37 | null | 3.399902 | 0.299988 | 0.799927 | 134 | null | null | null | null | 4 | null | <2 mo. follow-up | 3.183199 |
1,655 | 77.32495 | 1 | male | 0 | 7 | 34 | MOSF w/Malig | ARF/MOSF | 2 | 16 | >$50k | 0 | 12,638 | 8,273.2656 | null | 19 | white | 25.699219 | 48 | 0.603882 | 0.497986 | 3 | 0 | 0 | yes | 0 | 0 | no dnr | 7 | 107 | 100 | 82 | 30 | 37.69531 | 122.5 | null | 1.5 | 1.5 | 146 | 7.439453 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
1,656 | 73.91095 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 46,732 | 21,987.5 | null | 33.666657 | white | 19.097656 | 31 | 0.842896 | 0.78894 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 13 | 77 | 9.699219 | 80 | 30 | 38.39844 | 166 | null | null | 1.099854 | 133 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.598145 |
1,657 | 61.43997 | 0 | female | 0 | 12 | 1,990 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 9,601 | 7,848.5742 | null | 9 | black | 17.097656 | 35 | 0.823975 | 0.712891 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 12 | 77 | 6.199219 | 94 | 16 | 36 | null | null | null | 18.398438 | 137 | null | null | null | null | 5 | 3 | no(M2 and SIP pres) | 3 |
1,658 | 74.33795 | 1 | male | 0 | 8 | 85 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 6,024 | 4,765.9258 | null | 8 | white | 16.699219 | 36 | 0.856934 | 0.763916 | 1 | 0 | 0 | no | 0.8 | 0.4 | dnr after sadm | 1 | 81 | 9.5 | 84 | 32 | 37.29688 | 195.21875 | null | null | 1 | 142 | 7.319336 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.07666 |
1,659 | 51.461 | 0 | female | 0 | 27 | 1,989 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 37 | 30,321 | 23,567.2188 | null | 9.75 | white | 28.898438 | 64 | 0.529907 | 0.330994 | 1 | 0 | 0 | no | null | null | no dnr | 27 | 73 | 8.578125 | 140 | 22 | 38.59375 | 384 | 2.199707 | 17.699219 | 1.599854 | 135 | 7.379883 | null | null | null | null | null | SIP>=30 | 3.533203 |
1,660 | 61.98499 | 0 | male | 0 | 5 | 1,988 | Colon Cancer | Cancer | 1 | 20 | $11-$25k | 0 | 3,503 | 2,697.7246 | null | 4 | white | 16.5 | 16 | 0.828979 | 0.628906 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 5 | 93 | 10.599609 | 60 | 20 | 37 | null | null | null | 1.299805 | 138 | null | null | null | null | 3 | 2 | no(M2 and SIP pres) | 2 |
1,661 | 89.36597 | 1 | male | 0 | 5 | 167 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 4,119 | 3,051.9258 | null | 12 | white | 17.199219 | 30 | 0.815918 | 0.700928 | 1 | 0 | 0 | no | 0.9 | 0.5 | dnr after sadm | 2 | 73 | 4.899414 | 74 | 28 | 36.09375 | 276 | null | null | 1.299805 | 144 | 7.419922 | null | null | null | 6 | null | adl>=4 (>=5 if sur) | 4.527397 |
1,662 | 85.85596 | 1 | male | 0 | 12 | 69 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 10,144 | 7,912.125 | null | 14.5 | white | 21.398438 | 49 | 0.715942 | 0.557983 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 105 | 3.299805 | 78 | 22 | 35.89844 | 233.3125 | null | null | 3 | 140 | 7.289062 | null | null | null | 5 | 3 | adl>=4 (>=5 if sur) | 3 |
1,663 | 83.69299 | 1 | female | 0 | 7 | 1,237 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 9 | 8,571 | 7,353.4258 | null | 23 | white | 15.398438 | 21 | 0.839966 | 0.784912 | 1 | 0 | 1 | no | null | null | dnr before sadm | -1 | 60 | 9.398438 | 64 | 24 | 38.29688 | 266.625 | null | null | 0.599976 | 142 | 7.449219 | null | null | null | null | null | adl>=4 (>=5 if sur) | 4.782227 |
1,664 | 50.36798 | 1 | male | 0 | 7 | 427 | Lung Cancer | Cancer | 1 | 20 | >$50k | 0 | 10,558 | 7,541.6172 | null | 12 | white | 10.798828 | 11 | 0.833984 | 0.637939 | 1 | 0 | 0 | metastatic | 0.78 | 0.1 | no dnr | 7 | 103 | 11.099609 | 96 | 24 | 38.19531 | null | 3.899902 | null | 1.199951 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,665 | 69.435 | 0 | male | 0 | 3 | 1,985 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 2,722 | 1,893.0508 | null | 5 | white | 21 | 25 | 0.836914 | 0.73291 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 92 | 10.699219 | 74 | 20 | 36.39844 | 388 | null | null | 2.599609 | 136 | 7.419922 | null | null | null | null | null | no(M2 and SIP pres) | 1.954346 |
1,666 | 81.57196 | 1 | female | 1 | 33 | 33 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 42,506 | 25,386.0312 | null | 16.25 | white | 27.097656 | 41 | 0.615967 | 0.428955 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 26 | 113 | 6.899414 | 134 | 42 | 38.59375 | 304 | 2.699707 | 0.599976 | 0.899902 | 132 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.264648 |
1,667 | 75.16498 | 1 | male | 0 | 18 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 9 | 19,845 | null | null | 12 | null | 23.5 | 25 | 0.695923 | 0.60498 | 1 | 0 | 0 | yes | 0.8 | 0.6 | dnr before sadm | -1 | 83 | 6.699219 | 60 | 24 | 36.19531 | 188.3125 | 3.199707 | 1.099854 | 2.199707 | 141 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 3.395508 |
1,668 | 28.411 | 0 | female | 0 | 11 | 1,982 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 15,781 | 8,793.8828 | null | 16.5 | white | 24.5 | 36 | 0.895996 | 0.858887 | 1 | 0 | 0 | no | 0.95 | 0.94 | no dnr | 11 | 57 | 8.398438 | 117 | 44 | 38.39844 | 177.5 | 3.599609 | 0.399963 | 0.699951 | 137 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 2.370606 |
1,669 | 75.80298 | 1 | female | 0 | 15 | 265 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 20,469 | 11,248.2812 | null | 20.333328 | white | 25.199219 | 54 | 0.746948 | 0.667969 | 1 | 1 | 0 | no | 0.7 | 0.5 | no dnr | 15 | 130 | 20 | 126 | 36 | 38.59375 | 289 | null | null | 1.799805 | 143 | 7.399414 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.375977 |
1,670 | 40.77798 | 0 | male | 0 | 10 | 1,983 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 17 | $11-$25k | 0 | 15,497 | 6,732.6719 | null | 24.5 | white | 25.699219 | 50 | 0.856934 | 0.807983 | 1 | 1 | 0 | no | 0.95 | 0.8 | no dnr | 10 | 61 | 15 | 110 | 26 | 36.29688 | 386.625 | 2.299805 | null | 2 | 136 | 7.269531 | null | null | null | 1 | 0 | null | 0 |
1,671 | 63.10699 | 1 | male | 0 | 11 | 220 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 40,364 | 27,025.0312 | null | 20.5 | white | 20.398438 | 32 | 0.831909 | 0.725952 | 6 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 11 | 106 | 7.299805 | 62 | 6 | 34.79688 | 341 | null | null | 1.199951 | 134 | 7.509766 | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
1,672 | 81.40997 | 1 | female | 0 | 11 | 158 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 9 | 15,727 | 13,627.2422 | null | 26.5 | white | 18.597656 | 22 | 0.805908 | 0.741943 | 1 | 0 | 0 | no | 0.7 | 0.4 | no dnr | 11 | 61 | 5.199219 | 89 | 11 | 36.39844 | 210.1875 | null | null | 1.199951 | 139 | 7.439453 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.939453 |
1,673 | 83.51495 | 1 | female | 1 | 9 | 9 | Coma | Coma | 2 | 12 | under $11k | 100 | 21,857 | 9,337.4766 | null | 34.5 | white | 27.097656 | 49 | 0.019997 | 0.007999 | 3 | 0 | 0 | no | 0 | 0 | dnr after sadm | 6 | 133 | 18.796875 | 105 | 38 | 37.29688 | 208 | 2.899902 | null | 2.299805 | 133 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
1,674 | 46.27798 | 0 | male | 0 | 5 | 1,979 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 6,112 | 4,393.9492 | null | 15 | white | 15.5 | 10 | 0.774902 | 0.530884 | 1 | 0 | 0 | metastatic | 0.95 | 0.9 | no dnr | 5 | 93 | 8.699219 | 110 | 20 | 36.19531 | null | 3.299805 | null | 0.899902 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,675 | 65.06494 | 1 | male | 0 | 6 | 173 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 9,324 | 6,639.1523 | null | 18 | white | 6.5 | 11 | 0.862915 | 0.69397 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 6 | 87 | 7.799805 | 70 | 20 | 37 | null | 3.199707 | 0.5 | 1.199951 | 140 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,676 | 71.84399 | 0 | female | 0 | 142 | 1,978 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 100 | 247,553 | null | null | 34.25 | white | 25 | 36 | 0.199982 | 0.106995 | 33 | 0 | 0 | no | 0.9 | 0.9 | dnr after sadm | 17 | 108 | 13.298828 | 112 | 37 | 40.19531 | 308 | null | null | 0.699951 | 145 | 7.459961 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
1,677 | 57.85599 | 0 | female | 0 | 4 | 1,978 | Lung Cancer | Cancer | 1 | 11 | $11-$25k | 0 | 6,191 | 4,342.793 | null | 18 | black | 14.199219 | 7 | 0.773926 | 0.529907 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 99 | 6.099609 | 80 | 20 | 36.59375 | null | null | null | 1.199951 | 144 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.955811 |
1,678 | 91.35394 | 1 | female | 0 | 10 | 287 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 41 | 9,472 | 5,058.6484 | null | 14.5 | black | 20.296875 | 41 | 0.621948 | 0.517944 | 1 | 0 | 1 | no | 0.5 | 0.3 | dnr after sadm | 1 | 77 | 7.699219 | 104 | 26 | 37.29688 | 593.25 | 1.799805 | 0.699951 | 1.399902 | 156 | 7.419922 | null | null | null | null | null | adl>=4 (>=5 if sur) | 6.267578 |
1,679 | 84.32599 | 1 | male | 0 | 11 | 589 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 8,797 | 6,918.1875 | null | 15 | white | 23.097656 | 32 | 0.744995 | 0.598999 | 1 | 0 | 0 | no | 0.7 | 0.343 | no dnr | 11 | 82 | 8.699219 | 58 | 28 | 37 | 360 | null | null | 3.399902 | 140 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,680 | 69.74097 | 1 | male | 0 | 8 | 25 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 6,911 | 5,281.0781 | null | 8 | white | 40.398438 | 43 | 0.23999 | 0.028999 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 1 | 96 | 13.199219 | 94 | 18 | 37.5 | null | 2.399902 | 25.597656 | 1.299805 | 132 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
1,681 | 77.75995 | 1 | male | 1 | 37 | 37 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 35,881 | 29,816.2656 | null | 12.5 | white | 28 | 46 | 0.685913 | 0.518921 | 1 | 0 | 0 | no | 0.8 | 0.7 | dnr after sadm | 23 | 44 | 7.899414 | 76 | 24 | 35.79688 | 376.1875 | null | null | 1.599854 | 136 | 7.5 | null | null | null | 1 | 3 | <2 mo. follow-up | 3 |
1,682 | 50.59 | 0 | male | 0 | 26 | 1,973 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 17 | >$50k | 0 | 49,205 | 44,503.75 | null | 28.25 | white | 41.5 | 67 | 0.511963 | 0.395996 | 1 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 26 | 43 | 3.799805 | 78 | 10 | 36.19531 | 142 | 2.099609 | 0.399963 | 7 | 132 | 7.089844 | null | null | null | null | 0 | SIP>=30 | 0 |
1,683 | 73.336 | 1 | female | 0 | 25 | 1,944 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 50,127 | 37,894.8438 | null | 24.75 | white | 23.898438 | 36 | 0.726929 | 0.641968 | 7 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 25 | 109 | 12.298828 | 66 | 26 | 38.19531 | 147.5 | 3.099609 | 2.399902 | 1.399902 | 135 | 7.489258 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
1,684 | 82.60394 | 1 | female | 0 | 31 | 1,471 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 38,687 | 27,226.2812 | null | 12.25 | white | 23.398438 | 49 | 0.674927 | 0.579956 | 2 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 31 | 57 | 8 | 49 | 22 | 36.39844 | 300 | 3.399902 | 0.5 | 2.299805 | 134 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,685 | 52.49597 | 0 | male | 0 | 10 | 1,971 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | >$50k | 0 | 12,827 | 10,778.3125 | null | 25.5 | white | 28.597656 | 32 | 0.782959 | 0.711914 | 1 | 1 | 0 | no | 0.96 | 0.95 | no dnr | 10 | 116 | 5 | 51 | 24 | 36.59375 | 148.96875 | 2.199707 | 1.299805 | 2.199707 | 138 | 7.349609 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,686 | 82.34094 | 1 | male | 1 | 4 | 4 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 4 | null | 0 | 4,338 | 3,098.4258 | null | 11 | white | 25.699219 | 38 | 0.480957 | 0.278992 | 1 | 0 | 0 | no | 0.6 | 0.3 | dnr after sadm | 4 | 87 | 15 | 124 | 23 | 38.79688 | 246.40625 | 3.199707 | 7.199219 | 1.099854 | 136 | 7.529297 | null | null | null | null | null | <2 mo. follow-up | 2.725586 |
1,687 | 39.896 | 1 | male | 0 | 5 | 1,001 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 5,221 | 3,690.5723 | null | 8 | white | 17.898438 | 30 | 0.897949 | 0.828979 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 93 | 5.099609 | 104 | 28 | 37.29688 | null | 1.799805 | 1 | 1.299805 | 136 | null | null | null | null | null | null | null | 1.863525 |
1,688 | 70.83899 | 1 | male | 0 | 10 | 1,227 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 15,529 | 6,593.3281 | null | 18 | white | 23.296875 | 39 | 0.791992 | 0.665894 | 1 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 10 | 53 | 4.799805 | 52 | 28 | 36.59375 | 200 | 3.599609 | 0.199982 | 0.799927 | 137 | 7.429688 | null | null | null | 0 | null | SIP>=30 | 0.4948 |
1,689 | 66.61694 | 1 | male | 0 | 24 | 31 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 21,410 | 19,480.0312 | null | 10.333328 | white | 17.796875 | 22 | 0.803955 | 0.581909 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 4 | 86 | 2.699707 | 60 | 8 | 36.89844 | null | 3.399902 | 0.599976 | 0.899902 | 141 | null | null | null | null | 7 | 1 | <2 mo. follow-up | 1 |
1,690 | 45.06998 | 1 | female | 0 | 11 | 256 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 11,897 | 8,689.2031 | null | 13.5 | white | 19.898438 | 5 | 0.696899 | 0.408997 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 11 | 81 | 9.398438 | 80 | 20 | 37.79688 | null | 2.599609 | null | 0.899902 | 136 | null | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
1,691 | 54.28299 | 1 | female | 0 | 10 | 335 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $25-$50k | 0 | 15,118 | 6,624.2617 | null | 22.5 | white | 37.5 | 52 | 0.594971 | 0.487 | 1 | 0 | 0 | no | 0.8 | 0.65 | no dnr | 10 | 50 | 10 | 155 | 40 | 37.29688 | 95 | 3 | 1.799805 | 0.899902 | 140 | 7.289062 | null | null | null | null | 2 | null | 2 |
1,692 | 68.44897 | 1 | male | 1 | 172 | 172 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $11-$25k | 0 | 357,428 | 306,873.5 | null | 42 | white | 29.699219 | 60 | 0.606934 | 0.5 | 14 | 0 | 0 | no | 0.2 | 0.09 | no dnr | 172 | 107 | 15.699219 | 88 | 18 | 37.5 | 188.3125 | 2.099609 | 7.799805 | 7 | 134 | 7.40918 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
1,693 | 87.09698 | 1 | female | 0 | 27 | 71 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 42,836 | 33,844.75 | null | 21.5 | white | 18.898438 | 25 | 0.800903 | 0.679932 | 1 | 0 | 0 | no | null | null | no dnr | 27 | 104 | 24.597656 | 80 | 34 | 38 | 355.0625 | null | 0.599976 | 0.899902 | 130 | 7.40918 | null | null | null | 2 | 2 | no(M2 and SIP pres) | 2 |
1,694 | 90.81195 | 1 | female | 0 | 11 | 72 | CHF | COPD/CHF/Cirrhosis | 3 | null | under $11k | 0 | 40,846 | 6,658.1758 | null | 13 | white | 17.5 | 30 | 0.805908 | 0.68689 | 1 | 1 | 0 | no | 0.9 | 0.5 | no dnr | 11 | 111 | 8.398438 | 48 | 16 | 36.89844 | 293.3125 | 3.699707 | 0.399963 | 1.699951 | 138 | 7.429688 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,695 | 46.72699 | 1 | female | 0 | 4 | 452 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 2,666 | 2,077.2012 | null | 11 | white | 13.699219 | 11 | 0.909912 | 0.8479 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 77 | 9.898438 | 80 | 20 | 37.59375 | null | null | 1.099854 | 0.899902 | 143 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
1,696 | 65.20197 | 1 | male | 1 | 14 | 14 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 14 | under $11k | 9 | 14,254 | 11,676.5625 | null | 7.666664 | white | 24.898438 | 43 | 0.62793 | 0.44397 | 1 | 0 | 1 | no | null | 0.09 | dnr after sadm | 2 | 77 | 13.199219 | 54 | 24 | 35.69531 | 182.59375 | 2.299805 | 3 | 0.799927 | 142 | 7.469727 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
1,697 | 48.94998 | 1 | male | 0 | 25 | 161 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 34,640 | 29,713.7656 | null | 24 | white | 21.699219 | 34 | 0.886963 | 0.81189 | 1 | 1 | 0 | no | null | null | no dnr | 25 | 43 | 6.099609 | 69 | 20 | 36.09375 | 480 | 4.599609 | 0.899902 | 1.399902 | 133 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,698 | 80.70599 | 0 | female | 0 | 7 | 1,957 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 9 | 9,764 | 4,184.7578 | null | 28 | white | 21.199219 | 42 | 0.767944 | 0.69397 | 1 | 0 | 1 | no | 0.6 | 0.5 | dnr after sadm | 1 | 78 | 8.099609 | 73 | 28 | 37.5 | 204 | 3.899902 | null | 2.799805 | 147 | 6.959961 | null | null | null | null | 5 | null | 5 |
1,699 | 60.31497 | 1 | female | 0 | 23 | 49 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 26,095 | 19,613.9844 | null | 15 | black | 11.599609 | 25 | 0.93396 | 0.888916 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 23 | 69 | 8.599609 | 76 | 24 | 36.89844 | null | 4.099609 | 1.399902 | 1.299805 | 134 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
1,700 | 80.64099 | 1 | female | 0 | 9 | 56 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 8,667 | 6,495.2734 | null | 10 | white | 21.296875 | 35 | 0.757935 | 0.615967 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 9 | 93 | 11.5 | 84 | 22 | 36.69531 | 191.28125 | 3.199707 | null | 1.599854 | 136 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 4.333008 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.